Raymond James Financial lowered shares of Oscar Health (NYSE:OSCR – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Tuesday, MarketBeat.com reports.
Several other analysts also recently issued reports on the company. Piper Sandler reduced their price target on Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a research note on Monday, June 9th. Wall Street Zen downgraded Oscar Health from a “buy” rating to a “hold” rating in a research note on Sunday, June 8th. Finally, Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $16.50.
Read Our Latest Stock Report on OSCR
Oscar Health Stock Performance
Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm’s quarterly revenue was up 42.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.62 EPS. As a group, equities research analysts predict that Oscar Health will post 0.69 EPS for the current year.
Insider Activity
In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 24.39% of the company’s stock.
Institutional Trading of Oscar Health
Institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp lifted its position in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter worth $30,000. Larson Financial Group LLC lifted its position in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after buying an additional 2,512 shares during the last quarter. CWM LLC lifted its position in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after buying an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its position in shares of Oscar Health by 484.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after buying an additional 2,854 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
- Five stocks we like better than Oscar Health
- Are Penny Stocks a Good Fit for Your Portfolio?
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is IBM’s AI Transformation Powering a Sustained Rally?
- 3 Tickers Leading a Meme Stock Revival
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.